All offered medicinal products must be admitted to trading in Polish in accordance with the applicable provisions of the Pharmaceutical Law of 6 September 2001. (Journal of Laws of 2021, items 1977, 2120).

-. In the event that the Ordering Party allows the offer of products that do not meet the above provision, it will specify in col. 3 of Appendix No. 1 DETAILS:

(a) In the case of products which are not medicinal products, there shall be provisions permitting the placing of those products on the market in Polish.

b) All offered medical devices must be admitted to trading in accordance with the Act on medical devices of 7 April 2022 (Journal of Laws 2022.974, as amended)

c) All offered foodstuffs for particular nutritional uses must be approved in accordance with the Regulation of the Minister of Health of 16 September 2010 (Journal of Laws of 2015, item 1026).

d) All offered pharmaceutical raw materials must comply with the provisions of the Pharmaceutical Law

1.1. A THREE-CHAMBER BAG CONTAINING AMINO ACIDS, GLUCOSE, FATS (INCLUDING OMEGA 3 ACIDS), ELECTROLYTES FOR PARENTERAL NUTRITION VIA CENTRAL VEINS, WITH A NITROGEN CONTENT OF 4 TO 5 G OF NITROGEN IN THE VOLUME OFFERED

bag from 493 ml to 625 ml; 1 /1260

1.2. A THREE-CHAMBER BAG CONTAINING AMINO ACIDS, GLUCOSE, FATS (INCLUDING OMEGA 3 ACIDS), ELECTROLYTES; FOR PARENTERAL NUTRITION VIA CENTRAL VEINS, WITH A NITROGEN CONTENT OF 8 TO 10 G OF NITROGEN PER VOLUME OFFERED

bag from 986 ml to 1250 ml; 1 /1600

1.3. A THREE-CHAMBER BAG CONTAINING AMINO ACIDS, GLUCOSE, FATS (INCLUDING OMEGA 3 ACIDS), ELECTROLYTES; FOR PARENTERAL NUTRITION VIA CENTRAL VEINS, WITH A NITROGEN CONTENT OF 10 TO 12 G OF NITROGEN IN THE VOLUME OFFERED

bag from 1250 ml to 1477 ml; 1 /540

1.4. A THREE-CHAMBER BAG CONTAINING AMINO ACIDS, GLUCOSE, FATS (INCLUDING OMEGA 3 ACIDS), ELECTROLYTES FOR PARENTERAL NUTRITION VIA CENTRAL VEINS, WITH A NITROGEN CONTENT OF 15 TO 16 G OF NITROGEN IN THE VOLUME OFFERED

bag from 1875 ml to 1970 ml; 1 /100

Amino acid and electrolyte solution 10% or amino acid solution with a concentration of 8.5% without electrolytes

on. 500 ml 1 /50

Solution for intravenous infusions of trace elements

amp.10 ml 5 /2400

Preparation containing organic phosphates

vial of 20 ml, end to be drawn up. Development. to inf. 10 /80

Fat-soluble vitamins and water for intravenous administration for adults.

fiddle. 10 /1200

STANDARD AMINO ACIDS FOR PATIENTS WITH RENAL INSUFFICIENCY

op.250 ml 1 /250

STANDARD AMINO ACIDS FOR PATIENTS WITH HEPATIC INSUFFICIENCY

on. 500 ml 10 /100

16.1. LIQUID DIET FOR ORAL ADMINISTRATION FOR CANCER PATIENTS, CONTAINING IMMUNOMODULATORY COMPONENT (OMEGA-3 FATTY ACIDS: EPA 880 MG/100ML AND DHA 585 MG/100ML) AND VITAMIN D 7.85 ΜG/100ML, HYPERCALORIC (2.45 KCAL/ML), PROTEIN CONTENT MIN. 14.6 G/100 ML, RESIDUE-FREE, GLUTEN-FREE, OSMOLARITY 570 MOSMOL/L, RECOMMENDED FOR CANCER PATIENTS WITH MALNUTRITION OR THE RISK OF MALNUTRITION ASSOCIATED WITH IT. (MINIMUM TWO FLAVORS TO CHOOSE FROM)

but. 125 ml 4 /2000

16.2. LIQUID DIET FOR ORAL ADMINISTRATION SUPPORTING THE TREATMENT OF BEDSORES AND WOUNDS, COMPLETE, RESIDUE-FREE, HYPERCALORIC (1.24 KCAL/ML), GLUTEN-FREE, CONTAINING ARGININE ACCELERATING WOUND HEALING, PROTEIN CONTENT 8.8 G/100ML, LOW FAT CONTENT - 3.5G / 100ML, OSMOLARITY MIN. 500 MOSMOL/L (MINIMUM TWO FLAVORS TO CHOOSE FROM)

but. 200 ml 4 /400

16.3. HYPERCALORIC LIQUID DIET FOR ORAL ADMINISTRATION (2.4 KCAL/ML), PROTEIN CONTENT 14.4 G/100 ML, SOURCE OF PROTEIN ARE CASEIN AND WHEY, RESIDUE-FREE, GLUTEN-FREE, OSMOLARITY 570 MOSMOL/L, IN EIGHT FLAVORS (MINIMUM 4 FLAVORS TO CHOOSE FROM)

but. 125 ml 4 /4000

16.4. LIQUID DIET FOR ORAL ADMINISTRATION NORMALIZING GLYCAEMIA, COMPLETE, NORMOCALORIC (1.04 KCAL/ML), DOES NOT CONTAIN SUCROSE, GLUTEN-FREE, PROTEIN CONTENT NOT LESS THAN 4.9G/100ML. WITH AN OSMOLARITY OF 365 MOSMOL/L. (MINIMUM TWO FLAVORS TO CHOOSE FROM)

but. 200 ml 4 /400

16.5. CLEAR LIQUID PREPARATION BASED ON MALTODEXTRIN, DOES NOT CONTAIN PROTEIN. FOR USE IN SURGICAL PATIENTS FOR PREOPERATIVE HYDRATION. CONTAINS CARBOHYDRATES (12.6 G/100 ML) AND ELECTROLYTES, RESIDUE-FREE, GLUTEN-FREE, 100% ENERGY FROM CARBOHYDRATES, OSMOLARITY 240 MOSMOL/L

but. 200 ml 4 /600

16.6. LIQUID DIET FOR DOUSNTY SUPPLY, NUTRITIONALLY COMPLETE, HIGH ENERGY (240KCAL/100ML), CONTAINS FIBER 3.6G/100ML, GLUTEN-FREE, PROTEIN CONTENT 9.5G/100ML.

but. 125 ml 4 /25

16.7. POWDERED DIET INTENDED FOR PATIENTS WITH AN INCREASED DEMAND FOR PROTEIN WITH A CONTENT OF AT LEAST 87 G PROTEIN/100 G, GLUTEN-FREE it is also allowed to offer foodstuffs for particular nutritional purposes

on. 225 g 1 /500

16.8. A PRODUCT FOR RAPID CONCENTRATION OF LIQUIDS (BEVERAGES AND FOODS) WITHOUT STARCH, GLUTEN-FREE, LACTOSE-FREE.

on. 175 g 1 /30

ORAL, HIGH-CALORIE DIET (1.3 KCAL / ML), RICH IN RESIDUAL LIVER FAILURE, USED IN LIVER FAILURE WITH A HIGH CONTENT OF BRANCHED CHAIN AMINO ACIDS

op.200 ml 1 /500

ORAL DIET, HIGH-CALORIE (2.0 KCAL/ML), RICH STONE, USED IN RENAL FAILURE

but. 200 ml 1 /900

NUTRITIONALLY COMPLETE ORAL DIET, RICH PROTEIN (10G/100ML), HIGH-ENERGY (150KCAL/100ML), OSMOLARITY 385-435 MOSM/L, EPA CONTENT 500 MG, DHA 210 MG

on. 200 ml 1 /5000

TWO-CHAMBER BAG FOR PARENTERAL NUTRITION, VIA CENTRAL AND PERIPHERAL VEINS, CONTAINING AMINO ACIDS, GLUCOSE, ELECTROLYTES

1000 ml bag 1 /50

A COMPLETE, HIGH-ENERGY (1.5 KCAL/ML), HIGH-PROTEIN (MIN. 7.5 G PROTEIN/100 ML) ORAL DIET, BASED ON PEPTIDES. RICH IN MCTS, LACTOSE-FREE, RESIDUE-FREE, GLUTEN-FREE

on. 200 ml 1 /400

A HIGH-PROTEIN DIET (PROTEIN CONTENT MIN. 25 G/100G), HIGH-ENERGY DIET (4.29 KCAL/1G), RESIDUE-FREE DIET THAT IS A COMPOSITION OF ESSENTIAL NUTRIENTS AND VITAMINS, MICRO- AND MACROELEMENTS, LACTOSE-FREE, GLUTEN-FREE, RESIDUE-FREE WITH A NEUTRAL TASTE.

6 /50

22.1. A DIET CONTAINING AT LEAST 1.5 KCAL/ML, HIGH PROTEIN (WITH A PROTEIN CONTENT OF AT LEAST 7.5 G/100 ML), TUBE NUTRITION PREPARATION FOR PATIENTS WITH DIABETES,

on. 500 ml 1 /2000

22.2. COMPLETE DIET FOR ENTERAL TUBE FEEDING, CALORIFIC VALUE 1.2 KCAL/ML, PROTEIN CONTENT NOT LESS THAN 6G/100 ML, CONTAINING FISH OIL AND FIBRE, TUBE NUTRITION PREPARATION

on. 1000 ml 1 /1000

22.3. A COMPLETE DIET FOR ENTERAL FEEDING BY TUBE WITH A CALORIFIC VALUE OF 2.0 KCAL/ML, WITH A PROTEIN CONTENT OF NOT LESS THAN 10 G/100 ML, CONTAINING MONOUNSATURATED FATTY ACIDS, FISH OIL, MCT AND FIBER, WITH A LOW SODIUM CONTENT.

on. 500 ml 1 /400

22.4. DIET WITH A CALORIFIC VALUE OF 1.2 TO 1.3 KCAL/ML, HIGH PROTEIN (MIN 10G/100 ML) CONTAINING EPA DHA FATTY ACIDS, TUBE NUTRITION PREPARATION

on. 500 ml 1 /350

22.5. DIET FOR FEEDING TUBE, NUTRITIONALLY COMPLETE, NORMOCALORIE, NORMOPROTEIN, HIGH RESIDUE, FIBRE (1.5G/100ML)

on. 500 ml 1 /4000

22.6. DIET TO BE ADMINISTERED BY TUBE, HYPERCALORIC (PROVIDING A MINIMUM OF 1.5 KCAL PER 1 ML), HIGH PROTEIN (WITH A PROTEIN CONTENT OF AT LEAST 5.5 G/100 ML).

on. 500 ml 1 /4000

22.7. HIGH-CALORIE DIET MIN 1.5 KCAL/ML, HIGH-PROTEIN DIET (MIN 6G/100 ML) CONTAINING EPA DHA FATTY ACIDS (MIN 0.5G/100ML), TUBE NUTRITION PREPARATION

on. 500 ml 1 /1800

22.8. NORMOCALORIE, RESIDUE-FREE, READY-TO-USE, PEPTIDE DIET - CONTAINS WHEY PROTEIN HYDROLYSATE; DEDICATED TO PATIENTS WITH ABSORPTION AND/OR DIGESTION DISORDERS, TUBE NUTRITION PREPARATION

on. 500 ml 1 /3500

Aqua pro iniectione

on. 250 ml 1 /300

Aqua pro iniectione

op. 0.5 l without PVC with double sterile port and rubber stopper

1 /21 000

Aqua pro irrigatione - Water for irrigation

on. 500 ml 1 /1 000

Aqua pro irrigatione - Water for irrigation

on. 1000 ml 1 /1 500

GLUCOSUM 10%

Op. 0.5 l PVC-free with double sterile port and rubber stopper 1 /1 300

GLUCOSUM 20%

Op. 0.5 l PVC-free with double sterile port and rubber stopper 10 50

GLUCOSUM 40%

poj. 500 ml 10 /10

3.1. A THREE-CHAMBER BAG CONTAINING AMINO ACIDS, GLUCOSE, FATS (INCLUDING OMEGA 3 ACIDS), ELECTROLYTES FOR PARENTERAL NUTRITION VIA CENTRAL AND PERIPHERAL VEINS, WITH A NITROGEN CONTENT OF 3 TO 3.5 G OF NITROGEN IN THE VOLUME OFFERED

bag from 850 ml to 1000 ml; 1 /2000

3.2.A THREE-CHAMBER BAG CONTAINING AMINO ACIDS, GLUCOSE, FATS (INCLUDING OMEGA 3 ACIDS), ELECTROLYTES FOR PARENTERAL NUTRITION VIA CENTRAL AND PERIPHERAL VEINS, WITH A NITROGEN CONTENT OF 5.6 TO 6.2 G OF NITROGEN IN THE VOLUME OFFERED

bag from 1200 ml to 1250 ml; 1 /1200

3.3.THREE-CHAMBER BAG CONTAINING AMINO ACIDS, GLUCOSE, FATS (INCLUDING OMEGA 3 ACIDS), ELECTROLYTES FOR PARENTERAL NUTRITION VIA CENTRAL AND PERIPHERAL VEINS, WITH A NITROGEN CONTENT OF 6 TO 7.4 G OF NITROGEN IN THE OFFERED VOLUME

bag from 1400 ml to 1500 ml; 1 /400

GLUCOSUM 5%

Op. 0.25 l PVC-free with double sterile port and rubber stopper 1 /9 000

GLUCOSUM 5%

Op. 0.5 l PVC-free with double sterile port and rubber stopper 1 /18 000

GLUCOSUM 5%

Op. 250 ml PVC-free with double sterile port, 75 ml injectable, packaging compatible with a system guaranteeing non-contact cytostatic drug preparation - the ability to transfer the drug without the use of a needle is required by connecting the syringe in a way that guarantees a secure needle-free luer-lock connection. 1 9 000

GLUCOSUM 5%

Op. 500 ml PVC-free with double sterile port, 100 ml injectable, packaging compatible with a system that guarantees non-contact preparation of cytostatic drugs - it is required to be able to transfer the drug without the use of a needle by connecting the syringe in a way that guarantees a secure needle-free luer-lock connection. 1 /9 000

GLUCOSUM 5%

100 ml bag 1 /3 000

Glucosum 5% + Natrii Chloratum 0.9% at 2:1 ratio

Op. 0.5 l PVC-free with double sterile port and rubber stopper 1 /2 500

NATRII CHLORIDUM + KALII CHLORIDUM + CALCII CHLORIDUM

on. 500 ml 10 /150

NATRII CHLORIDUM + KALII CHLORIDUM + CALCII CHLORIDUM+NATRII LACTAS

on. 0.5 l 1 /10 000

Natrii chloridum 0.9%

1 l PVC-free pack with double sterile port and rubber stopper 1 /5 000

Natrii chloridum 0.9%

Op. 50 ml PVC-free with double sterile port and rubber stopper 1 /17 000

4.1. A THREE-CHAMBER BAG CONTAINING AMINO ACIDS, GLUCOSE, FATS, ELECTROLYTES FOR PARENTERAL NUTRITION VIA CENTRAL VEINS, WITH A NITROGEN CONTENT OF 5 TO 7 G OF NITROGEN IN THE VOLUME OFFERED

bag from 625 ml to 1030 ml; 1 /540

4.2. A THREE-CHAMBER BAG CONTAINING AMINO ACIDS, GLUCOSE, FATS, ELECTROLYTES FOR PARENTERAL NUTRITION VIA CENTRAL VEINS, WITH A NITROGEN CONTENT OF 8 TO 10.5 G OF NITROGEN IN THE VOLUME OFFERED

bag from 1250 ml to 1550 ml; 1 /900

4.3. A THREE-CHAMBER BAG CONTAINING AMINO ACIDS, GLUCOSE, FATS, ELECTROLYTES FOR PARENTERAL NUTRITION VIA CENTRAL VEINS, WITH A NITROGEN CONTENT OF 10.5 TO 15 G OF NITROGEN IN THE OFFERED VOLUME

bag from 1875 ml to 2060 ml; 1 /50

Natrii chloridum 0.9%

Op. 0.5 l PVC-free with double sterile port and rubber stopper 1 /74 000

0

Natrii chloridum 0.9%

Op. 0.25 l PVC-free with double sterile port and rubber stopper 1 74 000

Natrii chloridum 0.9%

Op. 0.1 l PVC-free with double sterile port and rubber stopper 1 /195 000

Natrii chloridum 0.9%

amp.10ml 50 /5 000

Natrii chloridum 0.9%

Op. 250 ml PVC-free with double sterile port, 75 ml injectable, packaging compatible with a system guaranteeing non-contact cytostatic drug preparation - the ability to transfer the drug without the use of a needle is required by connecting the syringe in a way that guarantees a secure needle-free luer-lock connection. 1 /32 000

Natrii chloridum 0.9%

Op. 100 ml PVC-free with double sterile port, 20 ml injectable, packaging compatible with a non-contact system for the preparation of cytostatic drugs - the ability to transfer the drug without the use of a needle is required by connecting the syringe in a way that guarantees a secure needle-free luer-lock connection. 1 /18 000

Natrii chloridum 0.9%

Op. 500 ml PVC-free with double sterile port, 100 ml injectable, packaging compatible with a system that guarantees non-contact preparation of cytostatic drugs - it is required to be able to transfer the drug without the use of a needle by connecting the syringe in a way that guarantees a secure needle-free luer-lock connection. 1 /30 000

Natrii chloridum 0.9%

Op. 50 ml PVC-free with double sterile port, 10 ml injectable, packaging compatible with a non-contact system for the preparation of cytostatic drugs - the ability to transfer the drug without the use of a needle is required by connecting the syringe in a way that guarantees a secure needle-free luer-lock connection. 1 /10 000

Natrii chloridum 0.9%

Op. 1000 ml PVC-free with double sterile port, 120 ml injectable, packaging compatible with a non-contact system for the preparation of cytostatic drugs - the ability to transfer the drug without the use of a needle is required by connecting the syringe in a way that guarantees a secure needle-free luer-lock connection. 1 /10 000

Natrii chloridum 0.9%

Op. 100ml PVC-free with double sterile port and rubber stopper, stand-up pack 1 /76 000

5.1. A THREE-CHAMBER BAG WITH A HIGH PROTEIN CONTENT DEDICATED TO INTENSIVE CARE UNITS, A HIGH-PROTEIN, LOW-GLUCOSE FORMULA WITH A FAT EMULSION CONTAINING OLIVE OIL, IN ORDER TO COVER THE DAILY PROTEIN REQUIREMENT WHILE AVOIDING EXCESSIVE FLUID AND GLUCOSE INTAKE; LOW RATIO OF NON-PROTEIN ENERGY TO NITROGEN, 93 KCAL/1G NITROGEN; HIGH NITROGEN CONTENT OF 9 G OF NITROGEN IN 1000 ML; COVERAGE OF PROTEIN REQUIREMENTS IS ABOUT 1.5/KG/DAY

1000ml bag 1 /1400

5.2. A THREE-CHAMBER BAG WITH A HIGH PROTEIN CONTENT DEDICATED TO INTENSIVE CARE UNITS, A HIGH-PROTEIN, LOW-GLUCOSE FORMULA WITH A FAT EMULSION CONTAINING OLIVE OIL, IN ORDER TO COVER THE DAILY PROTEIN REQUIREMENT WHILE AVOIDING EXCESSIVE FLUID AND GLUCOSE INTAKE; LOW RATIO OF NON-PROTEIN ENERGY TO NITROGEN, 93 KCAL/1G NITROGEN; HIGH NITROGEN CONTENT OF 9 G OF NITROGEN IN 1000 ML; COVERAGE OF PROTEIN REQUIREMENTS IS ABOUT 1.5/KG/DAY

1500ml bag 1 /400

Natrii chloridum 0.9%

Op. 500ml PVC-free with double. sterile port and rubber stopper, stand-up pack 10 /15,000

Natrii chloridum 0.9%

Sterile rinsing solution with spout or 500 ml pour bottle. 10 /1 000

Natrii chloridum 0.9%

on. 3 l 1 /2 000

Natrii chloridum 0.9%

“sterile solution - bottle

1000ml standing with a rubber stopper for rinsing during laparoscopic procedures" 1 /500

INTRAVENOUS INFUSION FLUID CONTAINING MAGENZ, SODIUM AND POTASSIUM SALTS, CONTAINING CITRATE ANION, OF OSMOTIC PRESSURE AND IONIC COMPOSITION SIMILAR TO THAT OF PLASMA

Op. 0.5 l PVC-free with double sterile port and rubber stopper 1 /10,000

ISOTONIC INFUSION FLUID FREE OF LACTATE AND CITRATE, FULLY BALANCED AND ADAPTED TO THE ELECTROLYTE COMPOSITION OF THE PLASMA

Op. 0.5 l PVC-free with double sterile port and rubber stopper 1 /30 000

INTRAVENOUS INFUSION FLUID CONTAINING MAGENZ, SODIUM AND POTASSIUM SALTS, WITH AN OSMOTIC PRESSURE AND IONIC COMPOSITION SIMILAR TO THAT OF BLOOD PLASMA

Op. 0.5 l PVC-free with double sterile port and rubber stopper 1 /90,000

Modified liquid gelatin solution with a concentration of 4%

op.500 ml 10 /150

6.1. A THREE-CHAMBER BAG WITH A HIGH PROTEIN CONTENT DEDICATED TO INTENSIVE CARE UNITS, USED DURING CONTINUOUS RENAL REPLACEMENT THERAPY TO COMPENSATE FOR THE LOSS OF AMINO ACIDS ON THE FILTER; THE RATIO OF NON-PROTEIN ENERGY TO NITROGEN IS 53 KCAL/G N; COVERING THE DAILY PROTEIN REQUIREMENT UP TO 2 G/KG/DAY (12 G N /1000 ML) 650 ml bag 1 400

6.2. A THREE-CHAMBER BAG WITH A HIGH PROTEIN CONTENT DEDICATED TO INTENSIVE CARE UNITS, USED DURING CONTINUOUS RENAL REPLACEMENT THERAPY TO COMPENSATE FOR THE LOSS OF AMINO ACIDS ON THE FILTER; THE RATIO OF NON-PROTEIN ENERGY TO NITROGEN IS 53 KCAL/G N; COVERING THE DAILY PROTEIN REQUIREMENT UP TO 2 G/KG/DAY (12 G N /1000 ML) 1000 ml bag 1 1500

6.3. A THREE-CHAMBER BAG WITH A HIGH PROTEIN CONTENT DEDICATED TO INTENSIVE CARE UNITS, USED DURING CONTINUOUS RENAL REPLACEMENT THERAPY TO COMPENSATE FOR THE LOSS OF AMINO ACIDS ON THE FILTER; THE RATIO OF NON-PROTEIN ENERGY TO NITROGEN IS 53 KCAL/G N; COVERING THE DAILY PROTEIN REQUIREMENT UP TO 2 G/KG/DAY (12 G N /1000 ML) 1500 ml bag 1 800

NUTRITIONAL PREPARATION CONTAINS ALANYL-GLUTAMINE DIPEPTIDE

but. 20 % 100 ml 1 500

EMULSION OF HIGH-PURIFIED FISH OIL

Violin.100 ml 1 10

FAT EMULSION 20%

on. 500 ml 10 5